![Andrew T. Blair](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew T. Blair
Nessuna posizione attualmente
Storia della carriera di Andrew T. Blair
Precedenti posizioni note di Andrew T. Blair
Società | Posizione | Inizio | Fine |
---|---|---|---|
AFFYMAX, INC. | Direttore Tecnico/Scientifico/R&S | 13/04/2011 | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
University of Texas Health Center | Corporate Officer/Principal | - | - |
PROTARA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Andrew T. Blair
University of Illinois | Undergraduate Degree |
Rush University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 2 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AFFYMAX, INC. | Health Technology |
Aziende private | 2 |
---|---|
Proteon Therapeutics, Inc.
![]() Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Andrew T. Blair
- Esperienza